Sign in / Join Now
ETFs & Funds
It's hard to get excited about a $400m company with an approved drug that treats 500 people in U.S. $
Grand Nagus Kelly
Lots of insiders exercising options and selling them soon after. That's exciting, if you're an insider.
the insurance companies,market,and RPTP need to agree on a lower cost some say its 250,000 dollars yr for treatment. Will take time
Add a reply...
Latest StockTalks »
people get RPTP breaking news and analysis by email alert.
Get email alerts on RPTP »
Raptor Pharmaceutical Corp.
Get latest price
From other sites
Raptor Pharmaceuticals Stock Sees Short Interest Drop 19.8%
at TheStreet (Sep 27, 2016)
SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces An Investigation Of The Board Of Directors Of Raptor Pharmaceutical Corp. -RPTP
at TheStreet (Sep 20, 2016)
RAPTOR PHARMACEUTICAL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of Raptor Pharmaceutical Corp. (RPTP) Over The Proposed Sale Of The Company To Horizon Pharma Plc
at TheStreet (Sep 19, 2016)
INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Raptor Pharmaceutical Corp. And Encourages Shareholders To Contact The Firm For Additional Information
at TheStreet (Sep 15, 2016)
Raptor Pharmaceuticals' (RPTP) Shares March Higher, Can It Continue?
at Zacks.com (Sep 15, 2016)